Pain Management - Foundation Chap 27 - Taylor Lpn

Front 1

Acute Pain

Back 1

Discomfort identified by sudden onset and relatively short duration, mild to severe intensity, and a steady decrease in intensity over several days or weeks.

Front 2

Discomfort identified by sudden onset and relatively short duration, mild to severe intensity, and a steady decrease in intensity over several days or weeks.

Back 2

Acute Pain

Front 3

Chronic nonmalignant pain or
Chronic benign pain

Back 3

Discomfort that occurs almost daily, has been present for at least 6 months, and ranges in intensity from mild to severe

Front 4

Discomfort that occurs almost daily, has been present for at least 6 months, and ranges in intensity from mild to severe

Back 4

Chronic nonmalignant pain or
Chronic benign pain

Front 5

Descending spinal cord pathway that transmits sensory impulses from the brain.

Back 5

Efferent Pain Pathway

Front 6

Efferent Pain Pathway

Back 6

Descending spinal cord pathway that transmits sensory impulses from the brain.

Front 7

Neuropathic pain that occurs after amputation with pain sensations referred to an area in the missing portion of the limb.

Back 7

Phantom Limb Pain

Front 8

Phantom Limb Pain

Back 8

Neuropathic pain that occurs after amputation with pain sensations referred to an area in the missing portion of the limb.

Front 9

Unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such.

Back 9

Pain

Front 10

Pain

Back 10

Unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such.

Front 11

Compound that blocks opioid effects on one receptor type while producing opioid effects on a second receptor type.

Back 11

Mixed Agonist - Antagonist

Front 12

Mixed Agonist - Antagonist

Back 12

Compound that blocks opioid effects on one receptor type while producing opioid effects on a second receptor type.

Front 13

Drug used to enhance the analgesic efficacy of opioids, treat concurrent symptoms that exacerbate pain and provide independent analgesia for specific types of pain.

Back 13

Adjuvant medication

Front 14

Adjuvant medication

Back 14

Drug used to enhance the analgesic efficacy of opioids, treat concurrent symptoms that exacerbate pain and provide independent analgesia for specific types of pain.

Front 15

Use of cold applications to reduce swelling

Back 15

cryotherapy

Front 16

cryotherapy

Back 16

Use of cold applications to reduce swelling

Front 17

Analgesics administered via a catheter that terminates in the epidural space.

Back 17

Epidural Analgesia

Front 18

Epidural Analgesia

Back 18

Analgesics administered via a catheter that terminates in the epidural space.

Front 19

Technique of focusing attention on stimuli other than pain.

Back 19

Distraction

Front 20

Distraction

Back 20

Technique of focusing attention on stimuli other than pain.

Front 21

Hypnosis

Back 21

State of heightened awareness and focused concentration. An altered state of consciousness when a person in more receptive to suggestion.

Front 22

State of heightened awareness and focused concentration. An altered state of consciousness when a person in more receptive to suggestion.

Back 22

Hypnosis

Front 23

Discomfort from the internal organs that is felt in another area of the body

Back 23

Referred pain

Front 24

Referred pain

Back 24

Discomfort from the internal organs that is felt in another area of the body

Front 25

Stress management strategy in which muscles are alternately tensed and relaxed.

Back 25

Progressive muscle relaxation

Front 26

Progressive muscle relaxation

Back 26

Stress management strategy in which muscles are alternately tensed and relaxed.

Front 27

Underlying pathology that causes pain.

Back 27

Noxious Stimulus

Front 28

Noxious Stimulus

Back 28

Underlying pathology that causes pain.

Front 29

Central Nervous system pathway that selectively inhibits pain transmission by sending signals back down to the dorsal horn of the spinal cord.

Back 29

Modulation

Front 30

Modulation

Back 30

Central Nervous system pathway that selectively inhibits pain transmission by sending signals back down to the dorsal horn of the spinal cord.

Front 31

Paroximal pain that extends along the course of one or more nerves

Back 31

Neuralgia

Front 32

Neuralgia

Back 32

Paroximal pain that extends along the course of one or more nerves

Front 33

Noxious stimulus that triggers electrical activity in the endings of afferent nerve fibers (nociceptors)

Back 33

Transduction

Front 34

Transduction

Back 34

Noxious stimulus that triggers electrical activity in the endings of afferent nerve fibers (nociceptors)

Front 35

Process of applying a low voltage electrical current to the skin through cutaneous electrodes

Back 35

Transcutaneous Electrical nerve stimulation (TENS)

Front 36

Transcutaneous Electrical nerve stimulation (TENS)

Back 36

Process of applying a low voltage electrical current to the skin through cutaneous electrodes

Front 37

Phenomenon of requiring larger and larger doses of an analgesic to achieve the same level of pain relief.

Back 37

Tolerance

Front 38

Tolerance

Back 38

Phenomenon of requiring larger and larger doses of an analgesic to achieve the same level of pain relief.

Front 39

Discomfort resulting when the blood supply of an area is restricted or cut off completely.

Back 39

Ischemic Pain

Front 40

Ischemic Pain

Back 40

Discomfort resulting when the blood supply of an area is restricted or cut off completely.

Front 41

Level of intensity at which pain becomes appreciable or perceptible

Back 41

Pain Threshold

Front 42

Pain Threshold

Back 42

Level of intensity at which pain becomes appreciable or perceptible

Front 43

Device that allows the client to control the delivery of intravenous or subcutaneous pain medication in a safe, effective manner through a programmable pump.

Back 43

Patient controlled analgesia

Front 44

Patient controlled analgesia

Back 44

Device that allows the client to control the delivery of intravenous or subcutaneous pain medication in a safe, effective manner through a programmable pump.

Front 45

Discomfort marked by repetitive painful episodes that may recur over a prolonged period or throughout a clients lifetime.

Back 45

Recurrent Acute Pain

Front 46

Recurrent Acute Pain

Back 46

Discomfort marked by repetitive painful episodes that may recur over a prolonged period or throughout a clients lifetime.

Front 47

Technique of monitoring negative thoughts and replacing them with positive ones.

Back 47

Reframing

Front 48

Reframing

Back 48

Technique of monitoring negative thoughts and replacing them with positive ones.

Front 49

Discomfort caused by stimulation of the cutaneous nerve endings in the skin.

Back 49

Cutaneous Pain

Front 50

Cutaneous Pain

Back 50

Discomfort caused by stimulation of the cutaneous nerve endings in the skin.

Front 51

Group of opiate-like substances produced naturally by the brain; these substances raise the pain threshold, produce sedation and euphoria, and promote a sense of well-being

Back 51

Endorphins

Front 52

Endorphins

Back 52

Group of opiate-like substances produced naturally by the brain; these substances raise the pain threshold, produce sedation and euphoria, and promote a sense of well-being

Front 53

Pain relief without producing anesthesia

Back 53

Analgesia

Front 54

Analgesia

Back 54

Pain relief without producing anesthesia

Front 55

Ascending spinal cord

Back 55

Afferent pain pathway

Front 56

Afferent pain pathway

Back 56

Ascending spinal cord

Front 57

Administration of analgesics into the subarachnoid space

Back 57

Intrathecal analgesia

Front 58

Intrathecal analgesia

Back 58

Administration of analgesics into the subarachnoid space

Front 59

Receptive neuron for painful sensations

Back 59

Nociceptor

Front 60

Nociceptor

Back 60

Receptive neuron for painful sensations

Front 61

Nonlocalized discomfort originating in tendons, ligaments and nerves

Back 61

Somatic Pain

Front 62

Somatic Pain

Back 62

Nonlocalized discomfort originating in tendons, ligaments and nerves

Front 63

Level of intensity or duration of pain that a person is willing to endure

Back 63

Pain Tolerance

Front 64

Pain Tolerance

Back 64

Level of intensity or duration of pain that a person is willing to endure

Front 65

Discomfort generally identified as long term (lasting longer than 6 months) that is persistent, nearly constant or recurrent and that produces significant negative changes in a persons life.

Back 65

Chronic Pain

Front 66

Chronic Pain

Back 66

Discomfort generally identified as long term (lasting longer than 6 months) that is persistent, nearly constant or recurrent and that produces significant negative changes in a persons life.

Front 67

Insertion of small needles into the skin at selected (hoku) sites

Back 67

Accupuncture

Front 68

Accupuncture

Back 68

Insertion of small needles into the skin at selected (hoku) sites

Front 69

Substance that relieves pain

Back 69

analgesic

Front 70

analgesic

Back 70

Substance that relieves pain

Front 71

Condition of acute abdominal pain

Back 71

Colic

Front 72

Colic

Back 72

Condition of acute abdominal pain

Front 73

Discomfort that occurs almost daily over a long period, has the potential for lasting months or years, and has a high probability of ending; also known as progressive pain.

Back 73

Chronic Acute Pain

Front 74

Chronic Acute Pain

Back 74

Discomfort that occurs almost daily over a long period, has the potential for lasting months or years, and has a high probability of ending; also known as progressive pain.

Front 75

Theory that proposes that the cognitive, sensory, emotional, and physiological components of the body can act together to block an individuals perception of pain.

Back 75

Gate control pain theory

Front 76

Gate control pain theory

Back 76

Theory that proposes that the cognitive, sensory, emotional, and physiological components of the body can act together to block an individuals perception of pain.

Front 77

Group of muscle disorders characterized by pain, muscle spasm, tenderness, stiffness and limited motion

Back 77

myofascial pain syndromes

Front 78

myofascial pain syndromes

Back 78

Group of muscle disorders characterized by pain, muscle spasm, tenderness, stiffness and limited motion

Front 79

Process by where the pain impulse travels from the receiving nociceptors to the spinal cord

Back 79

Transmission

Front 80

Transmission

Back 80

Process by where the pain impulse travels from the receiving nociceptors to the spinal cord

Front 81

Method used to decrease anxiety and muscle tension

Back 81

Relaxation Technique

Front 82

Relaxation Technique

Back 82

Method used to decrease anxiety and muscle tension

Front 83

Discomfort felt in the internal organs

Back 83

visceral pain

Front 84

visceral pain

Back 84

Discomfort felt in the internal organs

Front 85

Ability to experience, recognize, organize, and interpret sensory stimuli

Back 85

Perception

Front 86

Perception

Back 86

Ability to experience, recognize, organize, and interpret sensory stimuli

Front 87

Medication dosage beyond which no further analgesia occurs

Back 87

Ceiling effect

Front 88

Ceiling effect

Back 88

Medication dosage beyond which no further analgesia occurs

Front 89

APS

Back 89

American Pain Society

Front 90

AHCPR

Back 90

Agency for Health Care Policy and Research

Front 91

ATC

Back 91

Around the Clock

Front 92

EMLA

Back 92

Eutectic (Cream) mixture of local anesthetics

Front 93

IASP

Back 93

International Association for the Study of Pain

Front 94

MRI

Back 94

Magnetic Resonance Imaging

Front 95

NPO

Back 95

Nothing by mouth

Front 96

NSAID

Back 96

Nonsteroidal anti-inflammatory drug

Front 97

PCA

Back 97

Patient controlled analgesia

Front 98

PRN

Back 98

As required

Front 99

TAC

Back 99

Tetracaine, Adrenaline, Cocaine

Front 100

TENS

Back 100

Transcutaneous electrical nerve stimulation

Front 101

TMJ

Back 101

Temporomandibular joint

Front 102

VAS

Back 102

Visual Analog Scale

Front 103

WHO

Back 103

World Health Organization